Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
210 questions in 21 reviews · Lung Cancer
current versionsNo studies 15 · 7.1%Ungraded 2 · 1%Very low 15 · 7.1%Low 66 · 31.4%Moderate 50 · 23.8%High 62 · 29.5%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Annual low‐dose CT screening vs annual chest x‐ray Lung cancer mortality · Patients with lung cancer Screening for lung cancer (2013) · Cochrane | RR 0.8 [0.7, 0.92] | 1 study · 53454 participants | High |
Annual low‐dose CT screening vs annual chest x‐ray All‐cause mortality · Patients with lung cancer Screening for lung cancer (2013) · Cochrane | RR 0.94 [0.88, 1] | 1 study · 53454 participants | High |
Lung cancer screening with chest radiography +/‐ sputum cytology vs less intense screening Lung cancer mortality ‐ Annual chest x‐ray plus 4‐monthly cytology versus annual x‐ray alone · Patients with lung cancer Screening for lung cancer (2013) · Cochrane | RR 0.88 [0.74, 1.03] | 2 studies · 20427 participants | High |
Lung cancer screening with chest radiography +/‐ sputum cytology vs less intense screening All‐cause mortality ‐ More frequent chest x‐ray screening versus less frequent screening · Patients with lung cancer Screening for lung cancer (2013) · Cochrane | RR 1.01 [0.94, 1.08] | 4 studies · 170149 participants | Low |
Lung cancer screening with chest radiography +/‐ sputum cytology vs less intense screening All‐cause mortality ‐ Annual chest x‐ray plus 4‐monthly cytology versus annual x‐ray alone · Patients with lung cancer Screening for lung cancer (2013) · Cochrane | RR 1.03 [0.91, 1.15] | 1 study · 10040 participants | High |
Lung cancer screening with chest radiography +/‐ sputum cytology vs less intense screening Lung cancer 5‐year survival ‐ More frequent chest x‐ray screening versus less frequent screening · Patients with lung cancer Screening for lung cancer (2013) · Cochrane | RR 0.91 [0.84, 0.99] | 4 studies · 1775 participants | Low |
Lung cancer screening with chest radiography +/‐ sputum cytology vs less intense screening Lung cancer 5‐year survival ‐ Annual chest x‐ray plus 4‐monthly cytology versus annual x‐ray alone · Patients with lung cancer Screening for lung cancer (2013) · Cochrane | RR 0.83 [0.75, 0.92] | 1 study · 837 participants | Moderate |
Annual chest x‐ray screening vs usual care (no regular screening) Lung cancer mortality at 6 years of · Patients with lung cancer Screening for lung cancer (2013) · Cochrane | RR 0.91 [0.81, 1.03] | 1 study · 154901 participants | High |
Annual chest x‐ray screening vs usual care (no regular screening) Lung cancer mortality at 13 years of · Patients with lung cancer Screening for lung cancer (2013) · Cochrane | RR 0.99 [0.91, 1.07] | 1 study · 154901 participants | High |
Annual chest x‐ray screening vs usual care (no regular screening) Deaths from all causes (excluding deaths from PLCO cancers) · Patients with lung cancer Screening for lung cancer (2013) · Cochrane | RR 0.98 [0.96, 1.01] | 1 study · 154901 participants | High |